| GO:0005852 | eukaryotic translation initiation factor 3 complex | 8.33% (8/96) | 8.0 | 0.0 | 0.0 |
| GO:0005575 | cellular_component | 56.25% (54/96) | 1.49 | 0.0 | 0.0 |
| GO:0006413 | translational initiation | 8.33% (8/96) | 6.75 | 0.0 | 0.0 |
| GO:0032991 | protein-containing complex | 28.12% (27/96) | 2.6 | 0.0 | 0.0 |
| GO:0002183 | cytoplasmic translational initiation | 5.21% (5/96) | 8.05 | 0.0 | 0.0 |
| GO:0110165 | cellular anatomical entity | 43.75% (42/96) | 1.31 | 0.0 | 0.0 |
| GO:0031074 | nucleocytoplasmic transport complex | 3.12% (3/96) | 9.39 | 0.0 | 1e-06 |
| GO:0042565 | RNA nuclear export complex | 3.12% (3/96) | 9.39 | 0.0 | 1e-06 |
| GO:0000148 | 1,3-beta-D-glucan synthase complex | 4.17% (4/96) | 6.88 | 0.0 | 2e-06 |
| GO:0006074 | (1->3)-beta-D-glucan metabolic process | 4.17% (4/96) | 6.88 | 0.0 | 2e-06 |
| GO:0003843 | 1,3-beta-D-glucan synthase activity | 4.17% (4/96) | 6.88 | 0.0 | 2e-06 |
| GO:0006075 | (1->3)-beta-D-glucan biosynthetic process | 4.17% (4/96) | 6.88 | 0.0 | 2e-06 |
| GO:0043226 | organelle | 25.0% (24/96) | 1.62 | 1e-06 | 1.9e-05 |
| GO:0098797 | plasma membrane protein complex | 4.17% (4/96) | 5.95 | 1e-06 | 1.9e-05 |
| GO:0043229 | intracellular organelle | 25.0% (24/96) | 1.62 | 1e-06 | 2e-05 |
| GO:0003676 | nucleic acid binding | 21.88% (21/96) | 1.73 | 1e-06 | 2.6e-05 |
| GO:0051254 | positive regulation of RNA metabolic process | 6.25% (6/96) | 4.06 | 2e-06 | 5.1e-05 |
| GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 6.25% (6/96) | 3.98 | 3e-06 | 6.5e-05 |
| GO:0005049 | nuclear export signal receptor activity | 3.12% (3/96) | 6.73 | 4e-06 | 8e-05 |
| GO:0006611 | protein export from nucleus | 3.12% (3/96) | 6.74 | 3e-06 | 8.3e-05 |
| GO:0010113 | negative regulation of systemic acquired resistance | 2.08% (2/96) | 9.22 | 5e-06 | 0.000105 |
| GO:0002832 | negative regulation of response to biotic stimulus | 2.08% (2/96) | 9.22 | 5e-06 | 0.000105 |
| GO:0031348 | negative regulation of defense response | 2.08% (2/96) | 9.22 | 5e-06 | 0.000105 |
| GO:0032102 | negative regulation of response to external stimulus | 2.08% (2/96) | 9.15 | 6e-06 | 0.000111 |
| GO:0031325 | positive regulation of cellular metabolic process | 6.25% (6/96) | 3.71 | 7e-06 | 0.000137 |
| GO:0009987 | cellular process | 37.5% (36/96) | 1.03 | 9e-06 | 0.000154 |
| GO:0043231 | intracellular membrane-bounded organelle | 20.83% (20/96) | 1.57 | 1e-05 | 0.000164 |
| GO:0043227 | membrane-bounded organelle | 20.83% (20/96) | 1.56 | 1.1e-05 | 0.000177 |
| GO:0034476 | U5 snRNA 3'-end processing | 2.08% (2/96) | 8.36 | 1.8e-05 | 0.000207 |
| GO:0071047 | polyadenylation-dependent mRNA catabolic process | 2.08% (2/96) | 8.36 | 1.8e-05 | 0.000207 |
| GO:0034473 | U1 snRNA 3'-end processing | 2.08% (2/96) | 8.36 | 1.8e-05 | 0.000207 |
| GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 2.08% (2/96) | 8.36 | 1.8e-05 | 0.000207 |
| GO:0010558 | negative regulation of macromolecule biosynthetic process | 6.25% (6/96) | 3.56 | 1.3e-05 | 0.000212 |
| GO:0051173 | positive regulation of nitrogen compound metabolic process | 6.25% (6/96) | 3.51 | 1.6e-05 | 0.000225 |
| GO:0048522 | positive regulation of cellular process | 6.25% (6/96) | 3.54 | 1.5e-05 | 0.000226 |
| GO:0009893 | positive regulation of metabolic process | 6.25% (6/96) | 3.49 | 1.8e-05 | 0.000229 |
| GO:0009890 | negative regulation of biosynthetic process | 6.25% (6/96) | 3.52 | 1.6e-05 | 0.000231 |
| GO:0031327 | negative regulation of cellular biosynthetic process | 6.25% (6/96) | 3.52 | 1.6e-05 | 0.000232 |
| GO:0010604 | positive regulation of macromolecule metabolic process | 6.25% (6/96) | 3.49 | 1.8e-05 | 0.000235 |
| GO:0010605 | negative regulation of macromolecule metabolic process | 6.25% (6/96) | 3.39 | 2.6e-05 | 0.000272 |
| GO:0010112 | regulation of systemic acquired resistance | 2.08% (2/96) | 8.09 | 2.6e-05 | 0.000276 |
| GO:0051273 | beta-glucan metabolic process | 4.17% (4/96) | 4.6 | 2.6e-05 | 0.000278 |
| GO:0140142 | nucleocytoplasmic carrier activity | 3.12% (3/96) | 5.77 | 2.6e-05 | 0.000284 |
| GO:0031324 | negative regulation of cellular metabolic process | 6.25% (6/96) | 3.37 | 2.9e-05 | 0.000285 |
| GO:1903313 | positive regulation of mRNA metabolic process | 3.12% (3/96) | 5.72 | 2.8e-05 | 0.000287 |
| GO:0009892 | negative regulation of metabolic process | 6.25% (6/96) | 3.36 | 3e-05 | 0.000287 |
| GO:0051274 | beta-glucan biosynthetic process | 4.17% (4/96) | 4.6 | 2.6e-05 | 0.000291 |
| GO:1902494 | catalytic complex | 9.38% (9/96) | 2.52 | 3.1e-05 | 0.000292 |
| GO:0046907 | intracellular transport | 7.29% (7/96) | 2.97 | 3.5e-05 | 0.000316 |
| GO:1990234 | transferase complex | 7.29% (7/96) | 2.97 | 3.4e-05 | 0.000318 |
| GO:0048518 | positive regulation of biological process | 6.25% (6/96) | 3.28 | 4.1e-05 | 0.000363 |
| GO:0051649 | establishment of localization in cell | 7.29% (7/96) | 2.92 | 4.3e-05 | 0.000376 |
| GO:0005622 | intracellular anatomical structure | 3.12% (3/96) | 5.49 | 4.5e-05 | 0.000389 |
| GO:0005634 | nucleus | 13.54% (13/96) | 1.87 | 5.5e-05 | 0.000455 |
| GO:0003723 | RNA binding | 10.42% (10/96) | 2.24 | 5.4e-05 | 0.000456 |
| GO:0009250 | glucan biosynthetic process | 4.17% (4/96) | 4.23 | 6.7e-05 | 0.000549 |
| GO:0000976 | transcription cis-regulatory region binding | 5.21% (5/96) | 3.51 | 8.6e-05 | 0.000662 |
| GO:0001067 | transcription regulatory region nucleic acid binding | 5.21% (5/96) | 3.51 | 8.6e-05 | 0.000662 |
| GO:0046527 | glucosyltransferase activity | 5.21% (5/96) | 3.52 | 8.3e-05 | 0.000662 |
| GO:0071028 | nuclear mRNA surveillance | 2.08% (2/96) | 7.14 | 9.8e-05 | 0.000745 |
| GO:1903311 | regulation of mRNA metabolic process | 3.12% (3/96) | 5.08 | 0.000105 | 0.000785 |
| GO:0048523 | negative regulation of cellular process | 6.25% (6/96) | 2.99 | 0.000121 | 0.000879 |
| GO:1990837 | sequence-specific double-stranded DNA binding | 5.21% (5/96) | 3.4 | 0.000121 | 0.000893 |
| GO:0008150 | biological_process | 45.83% (44/96) | 0.72 | 0.000126 | 0.000895 |
| GO:0048519 | negative regulation of biological process | 6.25% (6/96) | 2.96 | 0.000134 | 0.000938 |
| GO:0003743 | translation initiation factor activity | 3.12% (3/96) | 4.94 | 0.00014 | 0.000953 |
| GO:0051169 | nuclear transport | 4.17% (4/96) | 3.94 | 0.000147 | 0.000959 |
| GO:0006913 | nucleocytoplasmic transport | 4.17% (4/96) | 3.94 | 0.000147 | 0.000959 |
| GO:0008278 | cohesin complex | 2.08% (2/96) | 6.88 | 0.000139 | 0.000961 |
| GO:0140104 | molecular carrier activity | 3.12% (3/96) | 4.9 | 0.000152 | 0.000974 |
| GO:0000271 | polysaccharide biosynthetic process | 4.17% (4/96) | 3.92 | 0.000155 | 0.000981 |
| GO:0043928 | exonucleolytic catabolism of deadenylated mRNA | 2.08% (2/96) | 6.84 | 0.000147 | 0.000986 |
| GO:0008239 | dipeptidyl-peptidase activity | 2.08% (2/96) | 6.79 | 0.000158 | 0.000987 |
| GO:0034475 | U4 snRNA 3'-end processing | 2.08% (2/96) | 6.78 | 0.000161 | 0.000991 |
| GO:0044042 | glucan metabolic process | 4.17% (4/96) | 3.82 | 0.000202 | 0.001084 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 11.46% (11/96) | 1.88 | 0.000201 | 0.00109 |
| GO:0071035 | nuclear polyadenylation-dependent rRNA catabolic process | 2.08% (2/96) | 6.62 | 0.000199 | 0.001096 |
| GO:0071029 | nuclear ncRNA surveillance | 2.08% (2/96) | 6.62 | 0.000199 | 0.001096 |
| GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process | 2.08% (2/96) | 6.62 | 0.000199 | 0.001096 |
| GO:0106354 | tRNA surveillance | 2.08% (2/96) | 6.62 | 0.000199 | 0.001096 |
| GO:0071046 | nuclear polyadenylation-dependent ncRNA catabolic process | 2.08% (2/96) | 6.62 | 0.000199 | 0.001096 |
| GO:0016078 | tRNA catabolic process | 2.08% (2/96) | 6.62 | 0.000199 | 0.001096 |
| GO:0043634 | polyadenylation-dependent ncRNA catabolic process | 2.08% (2/96) | 6.62 | 0.000199 | 0.001096 |
| GO:0043633 | polyadenylation-dependent RNA catabolic process | 2.08% (2/96) | 6.62 | 0.000199 | 0.001096 |
| GO:0010468 | regulation of gene expression | 11.46% (11/96) | 1.89 | 0.000189 | 0.001152 |
| GO:0030915 | Smc5-Smc6 complex | 2.08% (2/96) | 6.49 | 0.000239 | 0.00121 |
| GO:0106068 | SUMO ligase complex | 2.08% (2/96) | 6.49 | 0.000239 | 0.00121 |
| GO:0000467 | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.08% (2/96) | 6.52 | 0.000229 | 0.001212 |
| GO:0009889 | regulation of biosynthetic process | 11.46% (11/96) | 1.86 | 0.000235 | 0.001218 |
| GO:0031326 | regulation of cellular biosynthetic process | 11.46% (11/96) | 1.86 | 0.000234 | 0.001224 |
| GO:0031125 | rRNA 3'-end processing | 2.08% (2/96) | 6.45 | 0.000253 | 0.001266 |
| GO:0050657 | nucleic acid transport | 3.12% (3/96) | 4.55 | 0.000306 | 0.001455 |
| GO:0051236 | establishment of RNA localization | 3.12% (3/96) | 4.55 | 0.000306 | 0.001455 |
| GO:0050658 | RNA transport | 3.12% (3/96) | 4.55 | 0.000306 | 0.001455 |
| GO:0006405 | RNA export from nucleus | 3.12% (3/96) | 4.57 | 0.000297 | 0.001474 |
| GO:0051641 | cellular localization | 7.29% (7/96) | 2.46 | 0.000305 | 0.001495 |
| GO:0000177 | cytoplasmic exosome (RNase complex) | 2.08% (2/96) | 6.19 | 0.000365 | 0.001715 |
| GO:0005730 | nucleolus | 4.17% (4/96) | 3.58 | 0.000378 | 0.001758 |
| GO:0071027 | nuclear RNA surveillance | 2.08% (2/96) | 6.15 | 0.000382 | 0.001759 |
| GO:0048585 | negative regulation of response to stimulus | 2.08% (2/96) | 6.12 | 0.000399 | 0.001821 |
| GO:0000956 | nuclear-transcribed mRNA catabolic process | 3.12% (3/96) | 4.41 | 0.000408 | 0.001842 |
| GO:0060255 | regulation of macromolecule metabolic process | 11.46% (11/96) | 1.75 | 0.000433 | 0.001917 |
| GO:0071025 | RNA surveillance | 2.08% (2/96) | 6.06 | 0.000431 | 0.001926 |
| GO:0031323 | regulation of cellular metabolic process | 11.46% (11/96) | 1.74 | 0.000455 | 0.001996 |
| GO:0035251 | UDP-glucosyltransferase activity | 4.17% (4/96) | 3.48 | 0.000488 | 0.002098 |
| GO:0034472 | snRNA 3'-end processing | 2.08% (2/96) | 5.98 | 0.000487 | 0.002117 |
| GO:0016051 | carbohydrate biosynthetic process | 4.17% (4/96) | 3.44 | 0.000547 | 0.002227 |
| GO:0008135 | translation factor activity, RNA binding | 3.12% (3/96) | 4.28 | 0.000529 | 0.002235 |
| GO:0090079 | translation regulator activity, nucleic acid binding | 3.12% (3/96) | 4.28 | 0.000529 | 0.002235 |
| GO:0031328 | positive regulation of cellular biosynthetic process | 4.17% (4/96) | 3.44 | 0.000544 | 0.002236 |
| GO:0009891 | positive regulation of biosynthetic process | 4.17% (4/96) | 3.44 | 0.000544 | 0.002236 |
| GO:0010557 | positive regulation of macromolecule biosynthetic process | 4.17% (4/96) | 3.44 | 0.000544 | 0.002236 |
| GO:0000176 | nuclear exosome (RNase complex) | 2.08% (2/96) | 5.88 | 0.000558 | 0.002251 |
| GO:0016180 | snRNA processing | 2.08% (2/96) | 5.87 | 0.000563 | 0.002252 |
| GO:0034661 | ncRNA catabolic process | 2.08% (2/96) | 5.85 | 0.000579 | 0.002256 |
| GO:0016075 | rRNA catabolic process | 2.08% (2/96) | 5.85 | 0.000579 | 0.002256 |
| GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' | 2.08% (2/96) | 5.86 | 0.000573 | 0.002274 |
| GO:0019222 | regulation of metabolic process | 11.46% (11/96) | 1.7 | 0.000591 | 0.002286 |
| GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 3.12% (3/96) | 4.18 | 0.00065 | 0.002489 |
| GO:0010629 | negative regulation of gene expression | 4.17% (4/96) | 3.34 | 0.000699 | 0.002657 |
| GO:0005976 | polysaccharide metabolic process | 4.17% (4/96) | 3.33 | 0.000713 | 0.002687 |
| GO:0006402 | mRNA catabolic process | 3.12% (3/96) | 4.1 | 0.000764 | 0.002764 |
| GO:0005484 | SNAP receptor activity | 2.08% (2/96) | 5.65 | 0.00076 | 0.002772 |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 3.12% (3/96) | 4.1 | 0.00076 | 0.002794 |
| GO:0003690 | double-stranded DNA binding | 5.21% (5/96) | 2.83 | 0.00075 | 0.002805 |
| GO:0045182 | translation regulator activity | 3.12% (3/96) | 4.1 | 0.000758 | 0.002809 |
| GO:0050779 | RNA destabilization | 2.08% (2/96) | 5.58 | 0.000834 | 0.002948 |
| GO:0061157 | mRNA destabilization | 2.08% (2/96) | 5.58 | 0.000834 | 0.002948 |
| GO:0000178 | exosome (RNase complex) | 2.08% (2/96) | 5.6 | 0.000822 | 0.00295 |
| GO:0061014 | positive regulation of mRNA catabolic process | 2.08% (2/96) | 5.55 | 0.000879 | 0.003013 |
| GO:0031331 | positive regulation of cellular catabolic process | 2.08% (2/96) | 5.55 | 0.000879 | 0.003013 |
| GO:1905354 | exoribonuclease complex | 2.08% (2/96) | 5.56 | 0.00086 | 0.003015 |
| GO:0002831 | regulation of response to biotic stimulus | 2.08% (2/96) | 5.54 | 0.000892 | 0.003035 |
| GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 2.08% (2/96) | 5.55 | 0.000872 | 0.003037 |
| GO:0016758 | hexosyltransferase activity | 5.21% (5/96) | 2.74 | 0.000973 | 0.003286 |
| GO:0032101 | regulation of response to external stimulus | 2.08% (2/96) | 5.45 | 0.001006 | 0.003374 |
| GO:0051168 | nuclear export | 3.12% (3/96) | 3.95 | 0.001017 | 0.003384 |
| GO:0015931 | nucleobase-containing compound transport | 3.12% (3/96) | 3.93 | 0.001063 | 0.003513 |
| GO:0043488 | regulation of mRNA stability | 2.08% (2/96) | 5.4 | 0.001077 | 0.003532 |
| GO:0005737 | cytoplasm | 10.42% (10/96) | 1.69 | 0.001088 | 0.003543 |
| GO:0061013 | regulation of mRNA catabolic process | 2.08% (2/96) | 5.36 | 0.001127 | 0.003645 |
| GO:0006401 | RNA catabolic process | 3.12% (3/96) | 3.85 | 0.00124 | 0.003981 |
| GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 3.12% (3/96) | 3.84 | 0.001275 | 0.004067 |
| GO:0043487 | regulation of RNA stability | 2.08% (2/96) | 5.25 | 0.001325 | 0.004196 |
| GO:0046983 | protein dimerization activity | 4.17% (4/96) | 3.08 | 0.001353 | 0.004256 |
| GO:0000987 | cis-regulatory region sequence-specific DNA binding | 3.12% (3/96) | 3.75 | 0.001525 | 0.004762 |
| GO:0016073 | snRNA metabolic process | 2.08% (2/96) | 5.07 | 0.001677 | 0.005202 |
| GO:0031347 | regulation of defense response | 2.08% (2/96) | 5.05 | 0.001721 | 0.005304 |
| GO:1990070 | TRAPPI protein complex | 1.04% (1/96) | 9.15 | 0.001756 | 0.005374 |
| GO:0007062 | sister chromatid cohesion | 2.08% (2/96) | 5.01 | 0.001831 | 0.005565 |
| GO:0097159 | organic cyclic compound binding | 26.04% (25/96) | 0.86 | 0.001888 | 0.005702 |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.12% (3/96) | 3.61 | 0.00201 | 0.006029 |
| GO:0003674 | molecular_function | 50.0% (48/96) | 0.5 | 0.002262 | 0.006742 |
| GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3.12% (3/96) | 3.52 | 0.002387 | 0.007069 |
| GO:0051252 | regulation of RNA metabolic process | 8.33% (8/96) | 1.76 | 0.002577 | 0.007582 |
| GO:0008623 | CHRAC | 1.04% (1/96) | 8.44 | 0.002872 | 0.008394 |
| GO:0005886 | plasma membrane | 7.29% (7/96) | 1.89 | 0.002959 | 0.008596 |
| GO:0043565 | sequence-specific DNA binding | 5.21% (5/96) | 2.37 | 0.002995 | 0.008645 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 8.33% (8/96) | 1.71 | 0.003273 | 0.009271 |
| GO:0050794 | regulation of cellular process | 12.5% (12/96) | 1.31 | 0.003255 | 0.009278 |
| GO:0140513 | nuclear protein-containing complex | 6.25% (6/96) | 2.07 | 0.00325 | 0.009319 |
| GO:1902680 | positive regulation of RNA biosynthetic process | 3.12% (3/96) | 3.32 | 0.003538 | 0.009899 |
| GO:0045893 | positive regulation of DNA-templated transcription | 3.12% (3/96) | 3.32 | 0.003538 | 0.009899 |
| GO:0048193 | Golgi vesicle transport | 3.12% (3/96) | 3.29 | 0.003735 | 0.010386 |
| GO:0008194 | UDP-glycosyltransferase activity | 4.17% (4/96) | 2.63 | 0.004121 | 0.011388 |
| GO:0003682 | chromatin binding | 3.12% (3/96) | 3.22 | 0.004277 | 0.011748 |
| GO:0031329 | regulation of cellular catabolic process | 2.08% (2/96) | 4.33 | 0.004587 | 0.012526 |
| GO:0045892 | negative regulation of DNA-templated transcription | 2.08% (2/96) | 4.29 | 0.004833 | 0.012888 |
| GO:1902679 | negative regulation of RNA biosynthetic process | 2.08% (2/96) | 4.29 | 0.004833 | 0.012888 |
| GO:0098796 | membrane protein complex | 4.17% (4/96) | 2.58 | 0.004755 | 0.012906 |
| GO:0050789 | regulation of biological process | 12.5% (12/96) | 1.24 | 0.004814 | 0.012988 |
| GO:0006436 | tryptophanyl-tRNA aminoacylation | 1.04% (1/96) | 7.57 | 0.005259 | 0.013861 |
| GO:0004830 | tryptophan-tRNA ligase activity | 1.04% (1/96) | 7.57 | 0.005259 | 0.013861 |
| GO:0080134 | regulation of response to stress | 2.08% (2/96) | 4.22 | 0.005342 | 0.013999 |
| GO:0030674 | protein-macromolecule adaptor activity | 2.08% (2/96) | 4.2 | 0.005418 | 0.014039 |
| GO:1990071 | TRAPPII protein complex | 1.04% (1/96) | 7.52 | 0.005417 | 0.014116 |
| GO:0009896 | positive regulation of catabolic process | 2.08% (2/96) | 4.16 | 0.005715 | 0.014723 |
| GO:0016757 | glycosyltransferase activity | 5.21% (5/96) | 2.13 | 0.005986 | 0.015334 |
| GO:0004386 | helicase activity | 3.12% (3/96) | 3.02 | 0.006243 | 0.015905 |
| GO:0051253 | negative regulation of RNA metabolic process | 2.08% (2/96) | 4.08 | 0.006379 | 0.016161 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 8.33% (8/96) | 1.53 | 0.006824 | 0.017193 |
| GO:0034655 | nucleobase-containing compound catabolic process | 3.12% (3/96) | 2.95 | 0.007072 | 0.017718 |
| GO:0043228 | non-membrane-bounded organelle | 5.21% (5/96) | 2.06 | 0.007277 | 0.017746 |
| GO:0030691 | Noc2p-Noc3p complex | 1.04% (1/96) | 7.12 | 0.007164 | 0.017754 |
| GO:0030690 | Noc1p-Noc2p complex | 1.04% (1/96) | 7.12 | 0.007164 | 0.017754 |
| GO:0080090 | regulation of primary metabolic process | 8.33% (8/96) | 1.51 | 0.007205 | 0.01776 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 5.21% (5/96) | 2.06 | 0.007273 | 0.017831 |
| GO:0044237 | cellular metabolic process | 20.83% (20/96) | 0.83 | 0.007387 | 0.017917 |
| GO:0009059 | macromolecule biosynthetic process | 5.21% (5/96) | 2.04 | 0.007598 | 0.018331 |
| GO:0005794 | Golgi apparatus | 3.12% (3/96) | 2.89 | 0.007945 | 0.019068 |
| GO:0065007 | biological regulation | 12.5% (12/96) | 1.14 | 0.008304 | 0.019826 |
| GO:0044270 | cellular nitrogen compound catabolic process | 3.12% (3/96) | 2.83 | 0.008943 | 0.021021 |
| GO:0046700 | heterocycle catabolic process | 3.12% (3/96) | 2.83 | 0.008943 | 0.021021 |
| GO:0060090 | molecular adaptor activity | 2.08% (2/96) | 3.83 | 0.008879 | 0.021087 |
| GO:0000785 | chromatin | 2.08% (2/96) | 3.81 | 0.009131 | 0.021353 |
| GO:0031010 | ISWI-type complex | 1.04% (1/96) | 6.59 | 0.010332 | 0.023915 |
| GO:0031123 | RNA 3'-end processing | 2.08% (2/96) | 3.72 | 0.010318 | 0.024006 |
| GO:1990072 | TRAPPIII protein complex | 1.04% (1/96) | 6.57 | 0.01049 | 0.024158 |
| GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 2.08% (2/96) | 3.67 | 0.011011 | 0.025104 |
| GO:0008097 | 5S rRNA binding | 1.04% (1/96) | 6.5 | 0.010964 | 0.025123 |
| GO:0005459 | UDP-galactose transmembrane transporter activity | 1.04% (1/96) | 6.48 | 0.011122 | 0.025232 |
| GO:0070008 | serine-type exopeptidase activity | 2.08% (2/96) | 3.62 | 0.01181 | 0.02653 |
| GO:0006997 | nucleus organization | 1.04% (1/96) | 6.4 | 0.011754 | 0.026533 |
| GO:0006996 | organelle organization | 5.21% (5/96) | 1.88 | 0.011914 | 0.026631 |
| GO:0019439 | aromatic compound catabolic process | 3.12% (3/96) | 2.66 | 0.012275 | 0.027304 |
| GO:1901361 | organic cyclic compound catabolic process | 3.12% (3/96) | 2.63 | 0.012854 | 0.028317 |
| GO:0006399 | tRNA metabolic process | 3.12% (3/96) | 2.64 | 0.012821 | 0.028379 |
| GO:0050685 | positive regulation of mRNA processing | 1.04% (1/96) | 6.15 | 0.013962 | 0.030031 |
| GO:0033120 | positive regulation of RNA splicing | 1.04% (1/96) | 6.15 | 0.013962 | 0.030031 |
| GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 1.04% (1/96) | 6.15 | 0.013962 | 0.030031 |
| GO:0009793 | embryo development ending in seed dormancy | 1.04% (1/96) | 6.17 | 0.013804 | 0.030119 |
| GO:0009790 | embryo development | 1.04% (1/96) | 6.17 | 0.013804 | 0.030119 |
| GO:0030689 | Noc complex | 1.04% (1/96) | 6.14 | 0.01412 | 0.030228 |
| GO:0008622 | epsilon DNA polymerase complex | 1.04% (1/96) | 6.07 | 0.014749 | 0.031429 |
| GO:0005975 | carbohydrate metabolic process | 5.21% (5/96) | 1.8 | 0.014875 | 0.031548 |
| GO:0009894 | regulation of catabolic process | 2.08% (2/96) | 3.43 | 0.015009 | 0.031686 |
| GO:0006886 | intracellular protein transport | 3.12% (3/96) | 2.54 | 0.015216 | 0.031974 |
| GO:0004527 | exonuclease activity | 2.08% (2/96) | 3.4 | 0.015624 | 0.032682 |
| GO:0008865 | fructokinase activity | 1.04% (1/96) | 5.86 | 0.017108 | 0.035622 |
| GO:0033962 | P-body assembly | 1.04% (1/96) | 5.79 | 0.017893 | 0.037088 |
| GO:0005488 | binding | 32.29% (31/96) | 0.52 | 0.018251 | 0.037658 |
| GO:0004396 | hexokinase activity | 1.04% (1/96) | 5.74 | 0.018521 | 0.037872 |
| GO:0016071 | mRNA metabolic process | 3.12% (3/96) | 2.44 | 0.018452 | 0.037901 |
| GO:0006272 | leading strand elongation | 1.04% (1/96) | 5.69 | 0.019148 | 0.038979 |
| GO:0006000 | fructose metabolic process | 1.04% (1/96) | 5.63 | 0.019931 | 0.040394 |
| GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 1.04% (1/96) | 5.59 | 0.020557 | 0.041479 |
| GO:0030008 | TRAPP complex | 1.04% (1/96) | 5.54 | 0.02134 | 0.042867 |
| GO:0032993 | protein-DNA complex | 2.08% (2/96) | 3.14 | 0.022003 | 0.044005 |
| GO:0048583 | regulation of response to stimulus | 2.08% (2/96) | 3.11 | 0.022871 | 0.045543 |
| GO:0071840 | cellular component organization or biogenesis | 7.29% (7/96) | 1.31 | 0.023755 | 0.047097 |
